KinderPharm

  • Home
  • Our Company
    • About KinderPharm
    • Why KinderPharm?
    • Management
    • Advisory Board
    • Our Purpose
    • Our Partner
  • Services
    • Pediatric Regulatory
      • Protocol Development
      • Waivers and Deferrals
      • PIP and PSP Submission
    • Age Appropriate Formulation
      • Pediatric Formulation Development
    • Juvenile Toxicology
      • Juvenile Toxicology Study Design & Conduct
    • Pharmacometrics
      • PK Data Analysis
      • Modeling & Simulation
        • Physiologically Based Pharmacokinetic (PBPK)
        • Pediatric Extrapolation
        • Population PK (POP PK) & Sparse Sampling
    • Clinical Trials
  • Resources
    • FDA Pediatric Information
    • EMA Pediatric Information
    • Other Regions Pediatric Information
  • News & Events
    • News
    • Events
  • Contact Us

FDA will accept requests from sponsors to discuss MIDD approaches in medical product development

The Food and Drug Administration (FDA or Agency) is announcing a pilot program that affords sponsors or applicants who are selected for participation the opportunity to meet with Agency staff to discuss model-informed drug development (MIDD) approaches in medical product development. Meetings under the pilot program will be conducted by FDA’s Center for Drug Evaluation […]

KinderPharm LLC and Worldwide Clinical Trials Form Strategic Alliance

Companies first to deliver integrated, end-to-end, global pediatric drug development and clinical center of excellence EXTON, PA, and MORRISVILLE, NC, DATE – KinderPharm LLC, dedicated exclusively to pediatric clinical research, and Worldwide Clinical Trials Inc. (Worldwide), an award-winning, full-service CRO, today announced they have entered into a strategic alliance to deliver the world’s first single […]

X-rays and Children: FDA Issues Guidance to Minimize Dose

By: Vasum Peiris, M.D., M.P.H. In medicine, knowledge is power and the information and knowledge gained from medical imaging have transformed the way medicine is practiced in less than a generation. Advances in X-ray imaging have evolved dramatically and span simple projection X-ray examinations to sophisticated 3-D techniques (computed tomography or ‘CT’)  to fluoroscopy, which […]

Would Your Child Benefit from a Clinical Trial?

By: FDA Consumer Health Information You may have heard of clinical trials, and your doctor may even have suggested your child enroll in one. Clinical trials are voluntary research studies conducted in people and designed to answer specific questions about the safety and/or effectiveness of drugs, vaccines, other therapies, or new ways of using existing treatments. If […]

EMA/EC Meet to Further Improve the Implementation of the Paediatric Regulation

On March 20, 2018 the European Medicines Agency (EMA) and the European Commission organized a workshop to further improve the implemetation of the Paediatric Regulation.  The workshop follows the publication of the Commission’s ten-year report on implementation of the Paediatric Regulation and the state of paediatric medicines in the European Union. The aim of the […]

  • 1
  • 2
  • 3
  • …
  • 17
  • Next Page »
PKPD Inc logo

Search this website

Meet Us at Industry Events

Meet with us

Sign up for our Newsletter

Partner With Us For

  • Pediatric Regulatory
    • Protocol Development
    • Waivers and Deferrals
    • PIP and PSP Submission
  • Age Appropriate Formulation
    • Pediatric Formulation Development
  • Juvenile Toxicology
    • Juvenile Toxicology Study Design & Conduct
  • Pharmacometrics
    • PK Data Analysis
    • Modeling & Simulation
      • Physiologically Based Pharmacokinetic (PBPK)
      • Pediatric Extrapolation
      • Population PK (POP PK) & Sparse Sampling
  • Clinical Trials

Read Our Latest Tweets

  • New York Venture Summit - great place to meet new companies and investors. https://t.co/BpvYTwjklH July 19, 2017 11:32 pm
  • Thank you #LifeSciencesPA for hosting the #PAPavilion Looking forward to #BIO2018 in Boston. https://t.co/DMmvmSYItT June 27, 2017 12:35 am
  • Bringing Better Medicines to Children through collaborations at #BIO2017 KinderPharm CEO Dr Graham and American M… https://t.co/YLxQwVZGKw June 22, 2017 12:02 am
  • Follow Us on Twitter

Our Mission

We have a single mission, simply “Bringing Better Medicines to Children” – but as everybody involved in pediatric drug development knows, this is not simple.

Quick Links

  • Services
  • Management
  • Advisory Board
  • Contact Us
  • Careers

Our Locations

US Location
100 Arrandale Blvd. (Suite 101)
Exton, PA 19341 USA

UK Location
40 Bank Street Level 18 Canary Wharf,
London E14 5NR UK

Copyright © 2018 - KinderPharm LLC - Privacy Policy - Terms of Service - Log in